Showing results (131-140 of 167) with videos related to
Sort By:
Pageof 17
Bone Marrow Transplantation|February 1, 1996
Comparison of four cytokine regimens for mobilization of peripheral blood stem cells: IL-3 alone and combined with GM-CSF or G-CSFC S Rosenfeld, B Bolwell, A LeFever, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 24, 2001
Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancerJ Nemunaitis, F Khuri, I Ganly, et al.Cancer Gene Therapy|January 25, 2014
Vertically integrated translational studies of PDX1 as a therapeutic target for pancreatic cancer via a novel bifunctional RNAi platformJ Wu, S Liu, J Yu, et al.Cancer Gene Therapy|July 27, 1999
Phase I trial of interferon-gamma (IFN-gamma) retroviral vector administered intratumorally to patients with metastatic melanomaJ Nemunaitis, T Fong, J M Robbins, et al.Pharmaceutical Research|May 1, 1996
Interspecies pharmacokinetics of a novel hematoregulatory peptide (SK&F 107647) in rats, dogs, and oncologic patientsD R Brocks, M I Freed, D E Martin, et al.Journal for Immunotherapy of Cancer|March 28, 2017
Safety, tumor trafficking and immunogenicity of chimeric antigen receptor (CAR)-T cells specific for TAG-72 in colorectal cancerKristen M Hege, Emily K Bergsland, George A Fisher, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 7, 2000
Phase III trial of gemcitabine plus cisplatin versus cisplatin alone in patients with locally advanced or metastatic non-small-cell lung cancerA B Sandler, J Nemunaitis, C Denham, et al.Head & Neck|July 14, 2016
Cutaneous head and neck melanoma in OPTiM, a randomized phase 3 trial of talimogene laherparepvec versus granulocyte-macrophage colony-stimulating factor for the treatment of unresected stage IIIB/IIIC/IV melanomaRobert H I Andtbacka, Sanjiv S Agarwala, David W Ollila, et al.American Journal of Clinical Oncology|April 16, 1998
SK&F107647: a synthetic hematoregulatory peptide in patients with solid tumor malignancies: a phase I trialJ Nemunaitis, D E Martin, D L Willis, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 2023
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung CancerDavid H Johnson, Louis Fehrenbacher, William F Novotny, et al.Pageof 17